Peptides for active anti-cytokine immunization
AssigneeVaxconsulting
InventorJean-Francois Zagury
Life of this patent
Estimating the term…
Loading patent…
AssigneeVaxconsulting
InventorJean-Francois Zagury
Estimating the term…
Peptide of a size comprised between 5 and 40 amino acids, originating from a cytokine, in which at least one of its amino acids comprises at least one of its atoms separated by a distance d of less than 5 angströms from an atom of the receptor corresponding to said cytokine, the spacing d being evaluated on the basis of structural data, derivatives, immunogenic compounds comprising them, use of a peptide or peptide derivative or immunogenic compound for the preparation of a curative or preventative medicament intended for the treatment or prevention of diseases linked to an excess or to the presence of cytokines or for the treatment of an auto-immune disease and pharmaceutical compositions which contain at least one abovementioned peptide or peptide derivative or immunogenic compound as active ingredient.
An immunizing composition, comprising a pharmaceutically acceptable excipient and, as active ingredient, an isolated peptide consisting of 12 to 40 amino acid residues, said peptide originating from a human cytokine, wherein said isolated peptide comprises a sequence selected from the group consisting of SEQ ID NO:15 and SEQ ID NO:24.
An immunizing composition, comprising a pharmaceutically acceptable excipient, and as active ingredient, an isolated peptide, wherein said peptide comprises the 17 amino acid residue sequence of SEQ ID NO:17 and is less than 30 residues in length.
Dependencies are inferred from the claim text.